Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Oncotarget|November 3, 2016
Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatmentAndrea Botticelli, Ilaria Zizzari, Federica Mazzuca, et al.
Journal of Immunology Research|April 28, 2023
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease ActivityFulvia Ceccarelli, Francesco Natalucci, Alessandra Di Filippo, et al.
Critical Reviews in Oncology/Hematology|November 8, 2011
Current knowledge and open issues regarding bevacizumab in gynaecological neoplasmsFilippo Bellati, Chiara Napoletano, Maria Luisa Gasparri, et al.
International Journal of Clinical Oncology|September 6, 2011
Thinking twice before abandoning first-line chemotherapy in ovarian cancer: report of two cases and literature review. Passing from tri-weekly to weekly regimensClaudia Marchetti, Filippo Bellati, Angela Musella, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2007
Cancer testis antigen expression in primary and recurrent vulvar cancer: association with prognostic factorsFilippo Bellati, Chiara Napoletano, Elisabetta Tarquini, et al.
Plos One|May 15, 2026
Analysis of Torquetenovirus DNA levels in NSCLC patients treated with immune checkpoint inhibitorsLilia Cinti, Lucrezia Tuosto, Piergiorgio Roberto, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2007
A comparative analysis of serum and serum-free media for generation of clinical grade DCsChiara Napoletano, Dora Pinto, Filippo Bellati, et al.
American Journal of Obstetrics and Gynecology|January 2, 2008
MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapyChiara Napoletano, Filippo Bellati, Elisabetta Tarquini, et al.
International Journal of Molecular Sciences|March 28, 2026
ASGR2 and CLEC12A as Prognostically Relevant C-Type Lectin Hubs in GlioblastomaAngelica Pace, Caterina Alfano, Luca D'Angelo, et al.
International Journal of Molecular Sciences|November 26, 2022
Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-AnalysisFabio Scirocchi, Lidia Strigari, Alessandra Di Filippo, et al.
Pageof 7